Corporate News     19-Jan-24
Shilpa Medicare receives German, EU authorization for Amifampridine Tablets
Shilpa Medicare has received Marketing Authorization from Germany, EU for Amifampridine Tablets, 10 mg under the National Procedure. Amifampridine is used as a drug, predominantly in the treatment of a number of rare muscle diseases. Specifically, Amifampridine is used to treat Lambert-Eaton myasthenic syndrome (LEMS), a rare autoimmune disease.

This product has sales of about 20 M USD in Europe. As on date, there is one other approved generic in the market.

Previous News
  Shilpa Medicare sizzles after Unicycive gets positive results in clinical trials of OLC
 ( Hot Pursuit - 05-Jul-24   14:52 )
  Shilpa Medicare soars after arm receives permission to market Adalimumab Injection
 ( Hot Pursuit - 30-Jun-23   11:51 )
  Shilpa Medicare consolidated net profit declines 98.16% in the June 2021 quarter
 ( Results - Announcements 14-Aug-21   17:05 )
  Shilpa Medicare to hold board meeting
 ( Corporate News - 21-Jun-23   09:58 )
  Shilpa Medicare's Telangana facility gets Europe GMP Approval
 ( Hot Pursuit - 17-Apr-24   11:32 )
  Volumes soar at Shilpa Medicare Ltd counter
 ( Hot Pursuit - 17-Feb-23   14:30 )
  Shilpa Medicare board to mull rights issue
 ( Hot Pursuit - 21-Jun-23   08:43 )
  Shilpa Medicare consolidated net profit rises 277.39% in the March 2022 quarter
 ( Results - Announcements 23-May-22   17:38 )
  Shilpa Medicare consolidated net profit declines 22.72% in the March 2019 quarter
 ( Results - Announcements 27-May-19   17:37 )
  Shilpa Biologicals completes Human Clinical Studies of its Adalimumab biosimilar
 ( Corporate News - 19-Aug-22   15:53 )
  Shilpa Medicare gains on launching breast cancer drug
 ( Hot Pursuit - 19-Dec-22   12:01 )
Other Stories
  Board of Delhivery approves alteration in capital clause of MoA
  05-Jul-24   19:32
  J B Chemicals & Pharmaceuticals appoints director
  05-Jul-24   19:30
  Infosys announces resignation of senior management personnel
  05-Jul-24   19:22
  JLR Q1 FY25 retail sales up 9% on YoY basis
  05-Jul-24   19:08
  Bajaj Auto launches world's first CNG motorcycle 'Freedom'
  05-Jul-24   18:59
  Agenda for board meeting of Power Grid Corporation of India
  05-Jul-24   18:46
  Board of Bank of Baroda approves raising additional capital up to Rs 7,500 cr in FY25
  05-Jul-24   18:06
  Vipul to hold board meeting
  05-Jul-24   17:15
  Markobenz Ventures to convene board meeting
  05-Jul-24   17:15
  Dhanashree Electronics to declare Quarterly Result
  05-Jul-24   17:15
Back Top